← Evidence map

ArticleNeuro-oncology2018

PRMT5 as a druggable target for glioblastoma therapy.

Yeshavanth Kumar Banasavadi-Siddegowda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

68 papers cite itlatest 60 shown

2018
…
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 29106602